The current price of 7730.T is ¥1,454.00 — it has decreased by 5.71% since the previous close. Data as of Nov 6, 2026.
7730.T is down 3.32% over the past week, down 1.69% over the past month and down 1.29% over the past year. The price is below its 200-day moving average of ¥1,598.60.
Of the 7 analysts covering Mani, Inc., 1 rates it a strong buy, 3 rate it a buy and 3 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Mani, Inc. has a market capitalization of ¥143.22B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Mani, Inc. posted earnings of ¥16.19 per share against an estimate of ¥14.19, beating expectations by 14.09%. Upcoming reports are listed in the earnings calendar.
Mani, Inc. reported revenue of ¥8.53B in its most recent quarter, which has increased by 10.97% compared with the same quarter a year earlier. Analysts had expected ¥8.58B.
Yes. Mani, Inc. pays dividends semi-annually. The latest payment of ¥24.00 per share has a payment date of Aug 31, 2027, which corresponds to a dividend yield of 2.89%.
Companies most comparable to Mani, Inc. include HOYA Corporation, Asahi Intecc Co., Ltd., Nipro Corporation, Nakanishi Inc. and Menicon Co., Ltd.
In the latest trading session 7730.T moved between ¥1,445.00 and ¥1,501.00, a range of 3.85% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Mani, Inc. shows a strong sell rating today and a strong sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Mani, Inc. is sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks 7730.T has traded between ¥1,345.00 and ¥1,955.00. The current price is 25.63% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.